{"schema_version":"1","generated_at":"2026-11-17T04:31:25.279Z","data_as_of":null,"url":"https://www.findmykol.com/kol/philip-tracy","json_url":"https://www.findmykol.com/kol/philip-tracy/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"philip-tracy","name":"Philip Tracy","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Providence","state":"RI","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1891358057","orcid":"0009-0001-3020-8123","openalex":"A5047250047"},"summary":"Philip Tracy is an Oncology physician. OpenAlex indexes 9 publications with 713 citations (h-index 4).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":9,"cited_by_count":713,"h_index":4,"latest_activity_year":2025,"source":"works"},"prescribing":{"data_year":2020,"areas_total":1,"areas_shown":1,"areas":[{"area":"Cardiovascular","share_pct":100,"classes_total":1,"classes":[{"class":"Statin","setting":"prescribed","share_pct":100,"drugs":[{"name":"Atorvastatin Calcium","share_pct":100}],"max_beneficiaries":null}]}],"source":"medicare"},"publications":{"total":9,"shown":5,"withheld":4,"matched_by":"OpenAlex author record","recent":[{"title":"Management of Metastatic Hormone Receptor-Positive Breast Cancer Beyond CDK4/6 Inhibitors","year":2025,"journal":"Current Oncology Reports","source_url":"https://doi.org/10.1007/s11912-025-01689-9","status":"verified"},{"title":"Financial toxicity (FT) of targeted oral anticancer medications (TOAMs) in patients with metastatic non-small cell lung cancer (NSCLC): Do TOAMs confer higher rates of FT than parenteral (IV) therapies?","year":2025,"journal":"JCO Oncology Practice","source_url":"https://doi.org/10.1200/op.2025.21.10_suppl.229","status":"verified"},{"title":"Extramedullary immunoprivileged sites as a niche for residual and relapsed FLT3- ITD mutated AML: an unmet clinical need","year":2024,"journal":"Leukemia & lymphoma/Leukemia and lymphoma","source_url":"https://doi.org/10.1080/10428194.2024.2431880","status":"verified"},{"title":"Systematic Review and Network Meta-Analysis of Frontline Targeted Therapy in Chronic Lymphocytic Leukemia Shows Comparable Efficacy but Distinct Toxicity","year":2022,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2022-156499","status":"verified"},{"title":"Pulmonary Tumor Thrombotic Microangiopathy as a Cause of Pulmonary Hypertension","year":2021,"journal":"JACC Case Reports","source_url":"https://doi.org/10.1016/j.jaccas.2021.04.013","status":"verified"}],"source":"works"},"contact":{"address_1":"593 EDDY ST","city":"Providence","state":"RI","zip":"029034923","phone":"401-793-2920","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1891358057","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":4}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2026-05-18","provider_certified":"2026-05-18","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2020}},"methodology_url":"https://www.findmykol.com/about#methodology"}